Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study
(2018)
Journal Article
Mohan, D., Forman, J. R., Allinder, M., McEniery, C. M., Bolton, C. E., Cockcroft, J. R., MacNee, W., Fuld, J., Marchong, M., Gale, N. S., Fisk, M., Nagarajan, S., Cheriyan, J., Lomas, D. A., Calverley, P. M., Miller, B. E., Tal-Singer, R., Wilkinson, I. B., & Polkey, M. I. (2018). Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study. Thorax, 73(12), 1182-1185. https://doi.org/10.1136/thoraxjnl-2018-211556
Cardiovascular and skeletal muscle manifestations constitute important comorbidities in COPD, with systemic inflammation proposed as a common mechanistic link. Fibrinogen has prognostic role in COPD. We aimed to determine whether aortic stiffness and... Read More about Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.